1.Analysis of clinical features and pathogenic variants in a Chinese pedigree affected with congenital glycosylation disease.
Rui FAN ; Honghua LU ; Feiyu LU ; Xiaoping LI ; Shengnan ZHAO ; Hongfeng SHI ; Yining ZHANG
Chinese Journal of Medical Genetics 2022;39(1):43-47
OBJECTIVE:
To explore the clinical features and genetic basis for a Chinese pedigree diagnosed with congenital glycosylation disease (CGD).
METHODS:
Clinical manifestations of two brothers were analyzed. Whole exome sequencing was carried out for the sib pair. Suspected variants were verified by Sanger sequencing.
RESULTS:
Both the proband and her younger brother were found to carry compound heterozygous variants of the PMM2 gene, which included a known pathogenic mutation of c.395T>C (p.I132T) and a previously unreported c.448-1(delAG) in the 5' end of exon 6 of the gene.
CONCLUSION
The compound heterozygous variants of the PMM2 gene probably underlay the CGD in the sib pair.
Asians/genetics*
;
China
;
Female
;
Glycosylation
;
Humans
;
Male
;
Mutation
;
Pedigree
;
Whole Exome Sequencing
2.Analysis of C2ORF71 gene variant in a Chinese patient with retinitis pigmentosa.
Man LIU ; Yilu LU ; Yongxin MA
Chinese Journal of Medical Genetics 2022;39(1):52-55
OBJECTIVE:
To explore the genetic basis for a Chinese patient with retinitis pigmentosa (RP).
METHODS:
Whole exome sequencing (WES) was carried out to screen potential variant in the proband. Candidate variants were determined by taking consideration of clinical phenotype. Sanger sequencing was used to verify the variant in the proband and his parents.
RESULTS:
The proband was found to harbor compound heterozygous variants of c.8G>A (p.Cys3Tyr) and c.958_959insA (p.Arg320Glnfs*29) in the C2ORF71 gene, which has derived from his father and mother, respectively. Both variants were unreported previously. Based on the ACMG guidelines, they were predicted to be likely pathogenic and pathogenic, respectively.
CONCLUSION
The novel compound heterozygous variants of the C2ORF71 gene probably underlay the pathogenesis of RP in the proband. Above finding has enriched the spectrum of C2ORF71 gene mutations and facilitated genetic counseling for the family.
Asians/genetics*
;
China
;
Humans
;
Mutation
;
Pedigree
;
Retinitis Pigmentosa/genetics*
;
Whole Exome Sequencing
3.Clinical features and genetic analysis of a Chinese pedigree affected with X-linked adrenoleukodystrophy.
Lingen KONG ; Jinhua QIU ; Caiming LI ; Qianwu ZHOU ; Zhiwei QIU ; Shunzhi ZHUANG ; Jinxiu ZOU ; Yanxia ZHENG
Chinese Journal of Medical Genetics 2022;39(1):60-63
OBJECTIVE:
To analyze the clinical features and variants of ABCD1 gene in a Chinese pedigree affected with X-linked adrenoleukodystrophy.
METHODS:
Clinical data of the proband were collected and analyzed. Potential variant of the ABCD1 gene were analyzed by PCR and Sanger sequencing of the proband, his parents and 100 unrelated healthy individuals.
RESULTS:
The prominent features of the proband included cerebellar and brainstem lesions, along with increased serum level of very-long chain fatty acids. He was found to harbor a hemizygous c.1509delG (p.L504Sfs*54) variant of the ABCD1 gene, for which his mother was heterozygous. The same variant was not detected in his father and 100 healthy controls.
CONCLUSION
X-linked adrenoleukodystrophy has a variety of clinical manifestations. Discovery of the c.1509delG (p.L504Sfs*54), as a novel pathogenic variant of the ABCD1 gene, has enabled diagnosis and genetic counseling for this pedigree.
Adrenoleukodystrophy/genetics*
;
Asians/genetics*
;
China
;
Female
;
Genetic Testing
;
Humans
;
Male
;
Mutation
;
Pedigree
4.Clinical and genetic analysis of a Chinese pedigree affected with benign familial neonatal convulsion.
Feng ZENG ; Feifei SONG ; Huan KE ; Rui CHENG
Chinese Journal of Medical Genetics 2022;39(2):198-201
OBJECTIVE:
To analyze the clinical phenotype and genetic variant in a Chinese pedigree affected with benign familial neonatal convulsion (BFNC).
METHODS:
Clinical data and peripheral blood samples of the pedigree were obtained with informed consent. Whole exome sequencing (WES) was carried out for the proband. Candidate variants were verified by Sanger sequencing.
RESULTS:
The pedigree comprised 9 individuals, among whom 4 were affected, including 3 males and 1 female. All patients had developed seizures during the neonatal period, which had ceased in 4 to 6 months. One patient had recurrence in between 1 and 2 years old. Genetic testing has identified a novel nonsense c.810G>A (p.W270X) variant in exon 5 of the KCNQ2 gene, which has co-separated with the BFNC phenotype in the pedigree.
CONCLUSION
The patients from this pedigree have conformed to the diagnosis of BFNC with good prognosis, which was in keeping with previously reported cases. The heterozygous c.810G>A (p.W270X) nonsense variant of the KCNQ2 gene probably underlay the pathogenesis of BFNC in this pedigree, which has expanded the mutational spectrum of the disease.
Asians/genetics*
;
Child, Preschool
;
China
;
Epilepsy, Benign Neonatal/genetics*
;
Female
;
Genetic Testing
;
Humans
;
Infant
;
Male
;
Mutation
;
Pedigree
5.Identification of a rare platelet-specific antigen HPA-10bw allele among ethnic Han Chinese population in Shandong.
Jingru SHAO ; Wenchao LI ; Yingfang PAN ; Wenben QIAO ; Chuanfu ZHU ; Xiangmin NIE ; Yan LIU
Chinese Journal of Medical Genetics 2022;39(2):231-233
OBJECTIVE:
To study the polymorphism of human platelet antigen (HPA) system 10 among ethnic Han Chinese from Shandong, China so as to supplement the data of platelet donor bank in the region.
METHODS:
Peripheral blood samples of platelet donors from the region were genotyped for HPA-10 alleles by PCR-sequence specific primer (PCR-SSP) and direct sequencing.
RESULTS:
Among 1401 donors, a rare heterozygote carrier of HPA-10w (a+b+) was identified, which gave an allelic frequency of approximately 0.035%.
CONCLUSION
The detection of rare HPA-10bw antigen allele among ethnic Han Chinese from Shandong is useful for the diagnosis and prevention of neonatal alloimmune thrombocytopenia and post-transfusion purpura in the region.
Alleles
;
Antigens, Human Platelet/genetics*
;
Asians/genetics*
;
Gene Frequency
;
Genotype
;
Humans
;
Infant, Newborn
;
Polymorphism, Genetic
6.Pre-conception carrier screening for 21 inherited metabolic diseases in a Chinese population.
Xilin XU ; Wenbin HE ; Ying WANG ; Fei GONG ; Guangxiu LU ; Ge LIN ; Yueqiu TAN ; Juan DU
Chinese Journal of Medical Genetics 2022;39(3):269-275
OBJECTIVE:
To determine the carrier rate for 21 inherited metabolic diseases among a Chinese population of childbearing age.
METHODS:
A total of 897 unrelated healthy individuals (including 143 couples) were recruited, and DNA was extracted from their peripheral blood samples. Whole exome sequencing (WES) was carried out to screen potential variants among 54 genes associated with 21 inherited metabolic diseases. Pathogenic and likely pathogenic variants and unreported loss-of-function variants were analyzed.
RESULTS:
One hundred fourty types of pathogenic/likely pathogenic variants (with an overall number of 183) and unreported loss-of-function variants were detected, which yield a frequency of 0.20 per capita. A husband and wife were both found to carry pathogenic variants of the SLC25A13 gene and have given birth to a healthy baby with the aid of preimplantation genetic diagnosis. The detected variants have involved 40 genes, with the most common ones including ATP7B, SLC25A13, PAH, CBS and MMACHC. Based on the Hardy-Weinberg equilibrium, the incidence of the 21 inherited metabolic diseases in the population was approximately 1/1100, with the five diseases with higher incidence including citrullinemia, methylmalonic acidemia, Wilson disease, glycogen storage disease, and phenylketonuria.
CONCLUSION
This study has preliminarily determined the carrier rate and incidence of 21 inherited metabolic diseases among a Chinese population of childbearing age, which has provided valuable information for the design of neonatal screening program for inherited metabolic diseases. Pre-conception carrier screening can provide an important measure for the prevention of transmission of Mendelian disorders in the population.
Asians/genetics*
;
China
;
Exome
;
Female
;
Humans
;
Infant, Newborn
;
Metabolic Diseases/genetics*
;
Mitochondrial Membrane Transport Proteins/genetics*
;
Oxidoreductases/genetics*
;
Whole Exome Sequencing
7.Genetic and clinical analysis of KIF2A gene variant in a Chinese patient with complex cortical dysplasia and other brain malformations.
Shuangxi CHENG ; Qingming WANG ; Xiaochun HONG ; Aixin CHEN ; Haiming YUAN
Chinese Journal of Medical Genetics 2022;39(3):312-315
OBJECTIVE:
To explore the genetic basis for a child featuring complex cortical dysplasia and other brain malformations (CDCBM3).
METHODS:
Genomic DNA was extracted from peripheral blood samples from the patient and his parents. Whole exome sequencing (WES) was carried out for the family trio. Suspected variant was verified by Sanger sequencing.
RESULTS:
The proband, a 1-year-and-2-month old Chinese boy, had presented with motor developmental delay, lissencephaly, severe cognitive impairments, absent speech and congenital laryngomalacia. WES revealed that he has harbored a heterozygous missense variant of the KIF2A gene, namely NM_001098511.2: c.952G>A, p.Gly318Arg (GRCh37/hg19). The highly conserved residue is located around the ATP nucleotide-binding pocket in the kinesin motor domain (PM1). The variant was not found in the Genome Aggregation Database and the 1000 Genomes Project (PM2), and was predicted to be deleterious on the gene product by multiple in silico prediction tools (PP3). This variant was unreported previously and was de novo in origin (PS2). Based on the ACMG guidelines, it was categorized as likely pathogenic (PS2+PM1+PM2+PP3). Furthermore, the congenital laryngomalacia found in our patient was absent in previously reported CDCBM3 cases.
CONCLUSION
The novel variant of the KIF2A gene probably underlay the disorders in the proband. Above finding has expanded the phenotypic and mutational spectrum of CDCBM3.
Asians/genetics*
;
Brain
;
China
;
Humans
;
Infant
;
Kinesins/genetics*
;
Male
;
Malformations of Cortical Development/genetics*
;
Whole Exome Sequencing
8.Identification of c.196C>T nonsense RUNX2 variant in a Chinese patient with cleidocranial dysplasia.
Bingna ZHOU ; Wenbin ZHENG ; Jing HU ; Ou WANG ; Yan JIANG ; Weibo XIA ; Xiaoping XING ; Mei LI
Chinese Journal of Medical Genetics 2022;39(5):526-529
OBJECTIVE:
To detect the genetic variant of a child with cleidocranial dysplasia (CCD) and to find out the causation of the illness.
METHODS:
Gene variant was identified by the second generation targeted sequencing and Sanger sequencing.
RESULTS:
The gene sequencing revealed that the RUNX2 gene had c.196C>T(p.Glu66*) nonsense variant, which was predicted to be a pathogenic variant according to the ACMG guidelines(PVS1+PS2).
CONCLUSION
The variant of c.196C > T in the RUNX2 gene may be the cause of the child with CCD, and the novel variant enriches the RUNX2 gene variant spectrum.
Asians/genetics*
;
Child
;
China
;
Cleidocranial Dysplasia/genetics*
;
Core Binding Factor Alpha 1 Subunit/genetics*
;
Humans
;
Mutation
9.Genetic and clinical analysis of a novel GLB1 gene variant in a Chinese patient with GM1-gangliosidosis.
Shuangxi CHENG ; Qingming WANG ; Aixin CHEN ; Lingfang ZHOU ; Xiaochun HONG ; Haiming YUAN
Chinese Journal of Medical Genetics 2022;39(5):537-541
OBJECTIVE:
To explore the genotype-phenotype correlation of a case with GM1-gangliosidosis caused by compound heterogenic variants in GLB1.
METHODS:
Genomic DNA was extracted from peripheral blood samples from the patient and her parents. Trio-based whole-exome sequencing (WES) was performed for the family and suspected mutation was verified by Sanger sequencing.
RESULTS:
The proband, a 2-year-3-month old Chinese girl, presented with psychomotor deterioration, absent speech, intellectual disabilities and behavior problem. Trio-based WES has identified compound heterozygosity for 2 variants in the GLB1 gene: NM_000404.2:c.1343A>T, p.Asp448Val and c.1064A>C, p.Gln355Pro (GRCh37/hg19),which was inherited from the mother and father, respectively. Homozygous or compound heterozygous pathogenic variants in GLB1, encoding β-galactosidase, are responsible for GM1-gangliosidosis,an autosomal recessive lysosomal storage disorder characterized by variable degrees of neurodegeneration and skeletal abnormalities. The p.Asp448Val variant has been classified as pathogenic for GM1 gangliosidosis in medical literatures for the reason that functional studies demonstrated that expression of the p.Asp448Val variant in COS-1 cells resulted in no detectable β-galactosidase activity compared to wild type GLB1. The p.Gln355Pro variant has not been reported in literatures or database. The variant is highly conserved residue (PM1), and was not found in either the Genome Aggregation Database or the 1000 Genomes Project (PM2) and was predicted to have a deleterious effect on the gene product by multiple in silico prediction tools (PP3). Next, the β-galactosidase activity of the patient's peripheral blood leukocytes was determined by fluorescent method. The result was 0.0 nmol/mg. It showed that the p.Gln355Pro variant also resulted in loss of β-galactosidase activity, thus the variant was classified into clinical pathogenic variant.
CONCLUSION
Our study expands the mutational spectrum of the GLB1 gene and provides genetic counseling for the family.
Asians/genetics*
;
China
;
Female
;
G(M1) Ganglioside
;
Gangliosidosis, GM1/genetics*
;
Humans
;
Mutation
;
beta-Galactosidase/genetics*
10.A prospective study of the decision tree prediction model for attention deficit hyperactivity disorder in preschool children.
Xin-Xin HUANG ; Ping OU ; Qin-Fang QIAN ; Yan HUANG ; Yan-Xia WANG
Chinese Journal of Contemporary Pediatrics 2022;24(3):255-260
OBJECTIVES:
To study the clinical value of attention time combined with behavior scale in the screening of attention deficit hyperactivity disorder (ADHD) in preschool children.
METHODS:
A total of 200 preschool children with ADHD diagnosed in Fujian Maternal and Child Health Hospital from February 2019 to March 2020 were enrolled as the ADHD group. A total of 200 children who underwent physical examination in the hospital or kindergartens during the same period were enrolled as the control group. Attention time was recorded. Chinese Version of Swanson Nolan and Pelham, Version IV Scale-Parent Form (SNAP-IV) scale was used to evaluate symptoms. With clinical diagnosis as the gold standard, the decision tree analysis was used to evaluate the clinical value of attention time combined with behavior scale in the screening of ADHD.
RESULTS:
Compared with the control group, the ADHD group had significantly higher scores of SNAP-IV items 1, 4, 7, 8, 10, 11, 14, 15, 16, 18, 20, 21, and 22 (P<0.05) and a significantly shorter attention time (P<0.05). The variables with statistically significant differences between the two groups in univariate analysis were used as independent variables to establish a decision tree model. The accuracy of the model in predicting ADHD was 81%, that in predicting non-ADHD was 69%, and the overall accuracy was 75%, with an area under the ROC curve of 0.816 (95% CI: 0.774-0.857, P<0.001).
CONCLUSIONS
The decision tree model for screening ADHD in preschool children based on attention time and assessment results of behavior scale has a high accuracy and can be used for rapid screening of ADHD among children in clinical practice.
Asians
;
Attention Deficit Disorder with Hyperactivity/diagnosis*
;
Child, Preschool
;
Decision Trees
;
Humans
;
Mass Screening
;
Prospective Studies

Result Analysis
Print
Save
E-mail